Skip to main content
. Author manuscript; available in PMC: 2014 Aug 20.
Published in final edited form as: J Labelled Comp Radiopharm. 2014 Feb 17;57(5):371–377. doi: 10.1002/jlcr.3191

Table 3.

Optimization of [18F]FFNP labeling using the mesylate precursor (6)

Entry Precursor (mg) Base (mg) Solvent (ML) Temperature (°C) Incorporation yielda (%)
5 min 10 min 15 min
1 1.8 K2CO3/K222 0.4/2.8 MeCN (600) 50 45.8 52.8 /
2 1.8 K2CO3/K222 0.4/2.8 MeCN (600) 63 64.9 65.2 /
3 1.8 K2CO3/K222 0.6/3.4 MeCN (600) 70 43.7 43.6 /
4 1.8 K2CO3/K222 0.4/2.8 MeCN (600) 70 65.1 62.5 /
5 1.8 K2CO3/K222 0.25/1.4 MeCN (600) 70 46.7 45.0 /
6 1.8 K2CO3/K222 0.25/1.4 MeCN (300) 74 28 / /
7 1.8 K2CO3/K222 0.25/1.4 MeCN (600) 80 18 / /
8 1.8 K2CO3/K222 0.4/2.8 MeCN (600) 81 14, 29 / /
9 1.8 Bu4NOH 3.57 μL/1 M MeCN (600) 70 7.6 7.3 /
10 1.9 KHCO3/K222 0.41/2.8 MeCN (500) 80 18.8 (4min) 24.1 (8min) 26.9 (105°C/4min)
a

Determined by radio-TLC (silica/ethyl acetate).